• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Neuroblastoma

  • FDA Granted Accelerated Approval to Danyelza for Neuroblastoma
    January 16, 2021

    FDA Granted Accelerated Approval to Danyelza for Neuroblastoma

    Charles H. Weaver, MD
  • Improved Survival with (BUMEL) Chemotherapy in Pediatric Neuroblastoma
    January 29, 2016

    Improved Survival with (BUMEL) Chemotherapy in Pediatric Neuroblastoma

    Charles H. Weaver, MD
  • Genetic Variation Associated with Risk of Neuroblastoma
    January 25, 2012

    Genetic Variation Associated with Risk of Neuroblastoma

    Charles H. Weaver, MD
  • Autologous Blood Stem Cell Transplant Improves Survival for Neuroblastoma
    January 1, 2012

    Autologous Blood Stem Cell Transplant Improves Survival for Neuroblastoma

    Charles H. Weaver, MD
  • Chemotherapy and Autologous Stem Cell Transplant Improve Outcome for Children
    January 1, 2012

    Chemotherapy and Autologous Stem Cell Transplant Improve Outcome for Children

    Charles H. Weaver, MD
  • Unituxin® Approved for Treatment of Children with High-Risk Neuroblastoma
    February 24, 2010

    Unituxin® Approved for Treatment of Children with High-Risk Neuroblastoma

    Charles H. Weaver, MD
  • Neuroblastoma Survival has Improved
    December 30, 2009

    Neuroblastoma Survival has Improved

    Charles H. Weaver, MD
  • Good Prognosis for Neuroblastoma Patients Diagnosed Before 18 Months of Age
    March 8, 2009

    Good Prognosis for Neuroblastoma Patients Diagnosed Before 18 Months of Age

    Charles H. Weaver, MD
  • Vitamin Supplementation During Pregnancy Decreases Incidence of Neuroblastoma
    March 8, 2009

    Vitamin Supplementation During Pregnancy Decreases Incidence of Neuroblastoma

    Charles H. Weaver, MD
  • Surgery Alone Remains Primary Treatment for Stage I and II Neuroblastoma
    March 8, 2009

    Surgery Alone Remains Primary Treatment for Stage I and II Neuroblastoma

    Charles H. Weaver, MD
  • Gene Expression and Outcomes with Standard Therapy in Neuroblastoma
    November 7, 2007

    Gene Expression and Outcomes with Standard Therapy in Neuroblastoma

    Charles H. Weaver, MD
  • Hycamtin/Cyclophosphamide Delays Progression of Recurrent Neuroblastoma
    October 3, 2007

    Hycamtin/Cyclophosphamide Delays Progression of Recurrent Neuroblastoma

    Charles H. Weaver, MD
1 2
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
 

Loading Comments...